NURECA Financial Statement Analysis
|
||
|
The Revenues of NURECA have decreased by -56.44% YoY .
The Earnings Per Share (EPS) of NURECA has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
NURECA Last 5 Annual Financial Results
[BOM: 543264|NSE : NURECA]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹111 Cr | ₹256 Cr | ₹213 Cr | ₹99 Cr | ₹62 Cr |
| Expenses | ₹126 Cr | ₹200 Cr | ₹152 Cr | ₹90 Cr | ₹53 Cr |
| Operating Profit (Excl OI) | ₹-15 Cr | ₹56 Cr | ₹62 Cr | ₹9.69 Cr | ₹9.06 Cr |
| Other Income | ₹7.11 Cr | ₹7.70 Cr | ₹2.82 Cr | ₹0.06 Cr | ₹0.09 Cr |
| Interest | ₹0.45 Cr | ₹0.74 Cr | ₹1.60 Cr | ₹0.77 Cr | ₹0.24 Cr |
| Depreciation | ₹2.39 Cr | ₹1.48 Cr | ₹0.42 Cr | ₹0.37 Cr | ₹0.06 Cr |
| Profit Before Tax | ₹-11 Cr | ₹61 Cr | ₹62 Cr | ₹8.61 Cr | ₹8.84 Cr |
| Profit After Tax | ₹-8.25 Cr | ₹45 Cr | ₹46 Cr | ₹6.40 Cr | ₹6.23 Cr |
| Consolidated Net Profit | ₹-8.25 Cr | ₹45 Cr | ₹46 Cr | ₹6.40 Cr | ₹6.23 Cr |
| Earnings Per Share (Rs) | ₹-1.79 | ₹-8.25 | ₹44.96 | ₹46.37 | ₹6,395.00 |
| PAT Margin (%) | -1.79 | -7.08 | 16.64 | 20.62 | 6.18 |
| ROE(%) | -0.92 | -4.14 | 24.55 | 52.39 | 61.23 |
| ROCE(%) | -1.06 | -5.17 | 33.57 | 67.61 | 56.70 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.01 | 0.70 |
Key Financials |
||
| Market Cap | : | ₹ 238.0 Cr |
| Revenue (TTM) | : | ₹ 94.9 Cr |
| Net Profit(TTM) | : | ₹ -5.8 Cr |
| EPS (TTM) | : | ₹ -5.8 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| NURECA | 2.6% | -16.3% | -27.7% |
| POLY MEDICURE | 7.2% | -5.4% | 42.9% |
NURECA Revenues
[BOM: 543264|NSE : NURECA]
| Y-o-Y | -56.44 % |
| 5 Yr CAGR | 15.81 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹111 Cr | -56.44 | |
| Mar2023 | ₹256 Cr | 19.72 | |
| Mar2022 | ₹213 Cr | 114.69 | |
| Mar2021 | ₹99 Cr | 60.63 | |
| Mar2020 | ₹62 Cr | - | |
NURECA Operating Profit
[BOM: 543264|NSE : NURECA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹56 Cr | -9.80 | |
| Mar2022 | ₹62 Cr | 534.84 | |
| Mar2021 | ₹9.69 Cr | 7.06 | |
| Mar2020 | ₹9.06 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | -13.48% | Negative | |
| Mar2023 | 21.72% | -24.66 | |
| Mar2022 | 28.83% | 195.69 | |
| Mar2021 | 9.75% | -33.36 | |
| Mar2020 | 14.63% | - | |
NURECA Profit After Tax
[BOM: 543264|NSE : NURECA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-8.25 Cr | Negative | |
| Mar2023 | ₹45 Cr | -3.05 | |
| Mar2022 | ₹46 Cr | 625.16 | |
| Mar2021 | ₹6.40 Cr | 2.71 | |
| Mar2020 | ₹6.23 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -1.79 % | Negative | |
| Mar2023 | -7.08 % | Negative | |
| Mar2022 | 16.64 % | -19.30 | |
| Mar2021 | 20.62 % | 233.66 | |
| Mar2020 | 6.18 % | - | |
NURECA Earnings Per Share (EPS)
[BOM: 543264|NSE : NURECA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.79 | Negative | |
| Mar2023 | ₹-8.25 | Negative | |
| Mar2022 | ₹45 | -3.04 | |
| Mar2021 | ₹46 | -99.27 | |
| Mar2020 | ₹6,395 | - | |
NURECA Return on Capital Employed (ROCE)
[BOM: 543264|NSE : NURECA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -1.06% | Negative | |
| Mar2023 | -5.17% | Negative | |
| Mar2022 | 33.57% | -50.35 | |
| Mar2021 | 67.61% | 19.24 | |
| Mar2020 | 56.7% | - | |
NURECA Share Price vs Sensex
| Current Share Price | : | ₹238.0 |
| Current MarketCap | : | ₹ 238.0 Cr |
| Updated EOD on | : | Mar 10,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | 2.6% |
-16.3% |
-27.7% |
| SENSEX | 1.4% |
-5.3% |
0.3% |
NURECA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about NURECA Financials
How the annual revenues of NURECA have changed ?
The Revenues of NURECA have decreased by -56.44% YoY .
How the Earnings per Share (EPS) of NURECA have changed?
The Earnings Per Share (EPS) of NURECA has decreased by Negative YoY .
Check out Intrinsic Value of Peers of NURECA
|
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of NURECA LTD |
